Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-16

Clinical Trial Update: Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effectiveness of levetiracetam in treating body dysmorphic disorder has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Butler Hospital | Conditions: Body Dysmorphic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2010-11-16